Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): How new treatment modalities have affected ECMO utilization

Pediatrics

Volumn 106, Issue 6, 2000, Pages 1339-1343

  Hintz, Susan R ^a   Suttner, Denise M ^b   Sheehan, Arlene M ^a   Rhine, William D ^a   Van Meurs, Krisa P ^a  

^a STANFORD UNIVERSITY   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Exogenous surfactact therapy; Extracorporeal membrane oxygenation; High frequency oscillatory ventilation; Inhaled nitric oxide

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; SURFACTANT;

ARTICLE; COMORBIDITY; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTROLLED STUDY; DIAPHRAGM HERNIA; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; HIGH FREQUENCY OSCILLATION; HUMAN; HYPOXEMIA; MAJOR CLINICAL STUDY; MALE; MECONIUM ASPIRATION; NEWBORN; OXYGENATION; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; SEPSIS;

EID: 0033668585     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.106.6.1339     Document Type: Article

References (30)

1. Extracorporeal membrane oxygenation for newborn respiratory failure: 45 cases
2. High frequency ventilation
3. Prospective, randomized comparison of high-frequency oxygenation
4. High frequency oscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn
5. High-frequency oscillatory ventilation and nitric oxide: Alternative or complementary to ECMO
6. Inhaled nitric oxide and high frequency oscillatory ventilation in persistent pulmonary hypertension of the newborn
7. Morphology and function of pulmonary surfactant inhibition by meconium
8. Surfactant protein A concentrations in tracheal aspirate fluid from infants requiring extracorporeal membrane oxygenation
9. Multicenter study of surfactant (beractant) in treatment of term infants with severe respiratory failure
10. Surfactant treatment of full-term newborns with respiratory failure
11. The reduction in the need for ECMO by using surfactant in meconium aspiration syndrome
12. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
13. Nitric oxide inhalation: Effect of the ovine neonatal pulmonary and systemic circulations
14. Neonatal Inhaled Nitric Oxide Study: Inhaled NO in full-term and nearly full-term infants with hypoxic respiratory failure
15. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
16. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn
17. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome
18. ECMO in evolution: The impact of changing patient demographics and alternative therapies on ECMO
19. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: A randomized, double-masked, placebo-controlled, dose-response, multicenter study
20. Strategies to prevent chronic neonatal lung disease
21. Peroxynitrite is produced during human ARDS
22. How cytotoxic is nitric oxide?
23. Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide
24. Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension
25. Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure
26. Inhaled nitric oxide in neonates and children with pulmonary hypertension
27. High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group
28. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome
29. Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn